Pharmacy chains defend actions as landmark U.S. opioid trial nears its end

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. AMZN
10. META

Go back to Pharmacy chains defend actions as landmark U.S. opioid trial nears its end

Walmart (WMT) Reports Q3 Comp Sales Up 9.2%; 15.6% Two-Year Stack; Comp Transactions up 5.7%

November 16, 2021 7:04 AM EST

Walmart Inc. (NYSE: WMT):

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211116005768/en/

Third quarter highlights:

Walmart raises full-year guidanceWalmart U.S. comp sales above 6%, excluding fuelFY22 GAAP EPS of around $5.00; Adjusted EPS of around $6.40 versus prior guidance of $6.20-$6.35FY22 capital expenditures of around $13 billionTotal revenue was $140.5 billion, up 4.3%, negatively... More